Synthesis and Structure–Activity Relationship Studies of 4-((2-Hydroxy-3-methoxybenzyl)amino)benzenesulfonamide Derivatives as Potent and Selective Inhibitors of 12-Lipoxygenase

详细信息    查看全文

• 作者：Diane K. Luci ; J. Brian Jameson ; II ; Adam Yasgar ; Giovanni Diaz ; Netra Joshi ; Auric Kantz ; Kate Markham ; Steve Perry ; Norine Kuhn ; Jennifer Yeung ; Edward H. Kerns ; Lena Schultz ; Michael Holinstat ; Jerry L. Nadler ; David A. Taylor-Fishwick ; Ajit Jadhav ; Anton Simeonov ; Theodore R. Holman ; David J. Maloney
• 刊名：Journal of Medicinal Chemistry
• 出版年：2014
• 出版时间：January 23, 2014
• 年：2014
• 卷：57
• 期：2
• 页码：495-506
• 全文大小：434K
• ISSN：1520-4804

文摘

Human lipoxygenases (LOXs) are a family of iron-containing enzymes which catalyze the oxidation of polyunsaturated fatty acids to provide the corresponding bioactive hydroxyeicosatetraenoic acid (HETE) metabolites. These eicosanoid signaling molecules are involved in a number of physiologic responses such as platelet aggregation, inflammation, and cell proliferation. Our group has taken a particular interest in platelet-type 12-(S)-LOX (12-LOX) because of its demonstrated role in skin diseases, diabetes, platelet hemostasis, thrombosis, and cancer. Herein, we report the identification and medicinal chemistry optimization of a 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide-based scaffold. Top compounds, exemplified by 35 and 36, display nM potency against 12-LOX, excellent selectivity over related lipoxygenases and cyclooxygenases, and possess favorable ADME properties. In addition, both compounds inhibit PAR-4 induced aggregation and calcium mobilization in human platelets and reduce 12-HETE in 尾-cells.